Last week, a federal judge ruled that the Food and Drug Administration (FDA) cannot prohibit a pharmaceutical company from marketing its drugs for off-label uses if its claims are truthful and not ...

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Labeling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's ...

(MENAFN- EIN Presswire) EINPresswire/ -- What Is The Expected Cagr For The Pharmaceutical Label Market Through 2025? In recent times, there has been a robust growth in the size of the pharmaceutical ...

Resource Label is a national label company Founded in 1986, MedLit is based in New Jersey and North Carolina CORE invests in North American lower middle-market manufacturing, industrial technology, ...

Dublin, Dec. 10, 2019 (GLOBE NEWSWIRE) -- The "Pharmaceutical Labeling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ...

Analyst insight: The pharmaceutical industry is making significant progress in standardizing labels and serialization across supply chains. A group of U.S. pharmaceutical and healthcare providers have ...

Par Pharmaceutical last week asked a federal court to tell the FDA to back off and allow the company to detail docs about using its Megace ES to treat AIDS-related wasting. The appetite-stimulating ...

Researchers are asking for tougher penalties and fines for pharmaceutical companies that market drugs for "off label" promotion, according to a new study. Researchers describe ways that the ...

MONTREAL & VIENNA--(BUSINESS WIRE)--Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the discovery and development of novel pharmaceutical agents based on their proprietary ...

LEO Pharma has submitted a label expansion application to EMA to expand Anzupgo® (delgocitinib) cream to adolescent patients (12–17 years) with moderate to severe chronic hand eczema (CHE) for whom ...

Recent share performance and business snapshot Apellis Pharmaceuticals (APLS) has drawn fresh attention after a stretch of weaker share performance. The stock is around $18.94 and has recorded ...